comparemela.com

Latest Breaking News On - Akoya biosciences inc - Page 4 : comparemela.com

Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024

Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Akoya-biosciences
Priyam-shah
Akoya-bioscience
Spatial-biology-company
Akoya-biosciences-inc
Nasdaq
Report-first-quarter
Spatial-biology

Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024

Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Akoya-biosciences
Priyam-shah
Akoya-bioscience
Akoya-biosciences-inc
Nasdaq
Spatial-biology-company
Spatial-biology

Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024

MARLBOROUGH, Mass., April 22, 2024 (GLOBE NEWSWIRE) Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the first quarter

Priyam-shah
Akoya-biosciences
Akoya-bioscience
Akoya-biosciences-inc
Nasdaq
Spatial-biology-company

Kent Lake Capital LLC Sells 629,686 Shares of Akoya Biosciences, Inc. (NASDAQ:AKYA)

Kent Lake Capital LLC lowered its holdings in shares of Akoya Biosciences, Inc. (NASDAQ:AKYA – Free Report) by 84.3% in the 4th quarter, Holdings Channel.com reports. The fund owned 116,835 shares of the company’s stock after selling 629,686 shares during the period. Kent Lake Capital LLC’s holdings in Akoya Biosciences were worth $570,000 at the […]

United-states
America
Brian-mckelligon
Akoya-biosciences
Asia-pacific
Blackrock-inc
Nasdaq
Unisuper-management-pty-ltd
Kennedy-capital-management
Kent-lake-capital
Canaccord-genuity-group
Akoya-biosciences-inc

Akoya Biosciences, Inc. (NASDAQ:AKYA) Receives $9.07 Consensus Target Price from Brokerages

Akoya Biosciences, Inc. (NASDAQ:AKYA) Receives $9.07 Consensus Target Price from Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states
America
Akoya-biosciences
Brian-mckelligon
Asia-pacific
Securities-exchange-commission
Canaccord-genuity-group
Lazard-asset-management
Jpmorgan-chase-co
Akoya-biosciences-inc
Citigroup-inc
Barclays-plc
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.